TMO Related New Coverage
-
Jefferies Assumes Thermo Fisher Scientific (TMO) at Buy
-
Barclays Assumes Coverage on Thermo Fisher Scientific (TMO) at Overweight
-
WallachBeth Capital Starts Thermo Fisher Scientific (TMO) at Buy
-
ISI Initiates Coverage on 15 Medical Supply Cos.; Top (ICLR) (PKI) (TMO) (HOLX) (A)
-
Wells Fargo Starts Thermo Fisher Scientific (TMO) at Market Perform; Returns on Capital Not So Hot
-
Morgan Stanley Starts Thermo Fisher Scientific (TMO) at Overweight
-
Cantor Fitzgerald Starts Thermo Fisher Scientific (TMO) at Buy; Leading the Way for Life Science Tools
-
Oppenheimer Starts Thermo Fisher Scientific (TMO) at Outperform
-
Goldman Sachs Resumes Thermo Fisher Scientific (TMO) at Buy
-
UPDATE - Barclays Initiates Coverage on Thermo Fisher Scientific (TMO) with an Overweight; Dionex Model Update
-
Barclays Starts Thermo Fisher Scientific (TMO) at Overweight, $64 Price Target
-
Barclays Starts Thermo Fisher Scientific (TMO) at Overweight
-
Mizuho Securities Starts Thermo Fisher Scientific (TMO) at Outperform
-
Gleacher & Co Initiates Coverage on Thermo Fisher (TMO) with a Buy
-
Goldman Sachs Starts MTD, A, SIAL, BRKR, LIFE, TMO at Neutral
-
Lazard Capital Initiates Coverage on Thermo Fisher Scientific (TMO) with a Hold
-
Auriga Initiates Coverage on Thermo Fisher Scientific (TMO) with a 'Hold'; Core Business Remains Well Positioned
-
Citi Initiates Coverage on Thermo Fisher Scientific (TMO); Discipline and Diversity Lead to Outperformance
-
Citi Initiates Coverage on Scientific and Technical Instuments Stocks
-
Credit Agricole Starts Scientific Instrument Stocks: WAT, LIFE, A at Buy, MTD, SIAL at Underperform
-
Jefferies & Co Initiates Coverage on Thermo Fisher Scientific (TMO) with a Hold
-
Morgan Stanley Starts Thermo Fisher Scientific (TMO) at Overweight
-
Auriga Initiates Coverage on Life Technologies (LIFE) with a Buy
-
Wall Street Access Starts Thermo Fisher Scientific (TMO) at Buy
-
Banc of America Starts Thermo Fisher Scientific (TMO) at Buy
-
Deutsche Bank Starts Waters (WAT) at Hold
-
Lehman Brothers reinstates coverage on Thermo Fisher Scientific (TMO) with an Overweight rating
Back to TMO Stock Lookup
